Company intelligence / Profile preview

Aventura Pharmaceuticals, LLC

Ownership: Private
Development stage: Commercial

Overview

Aventura Pharmaceuticals produces Elfolate and Elfolate Plus, which contain L-methylfolate used to treat and prevent low levels of folate in the body. These products are available without prescription and are recommended in combination with other medications for patients with depression, dementia, MTHFR gene mutations, and diabetic peripheral neuropathy[2][3].

Therapeutic areas: Metabolic DisordersPsychiatryEndocrinologyNeurology
Modalities: Medical foodsnutritional supplements
Industry: Food & Nutrition

Drug pipeline

2 assets

l-methylfolate

Commercial

Indications: Depression, Dementia, MTHFR gene mutations

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Aventura Pharmaceuticals, LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aventura Pharmaceuticals, LLC.

Explore the full profile